TrialCancer immunology, immunotherapy : CII2014

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.

Sander Kelderman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.